Related Experiment Video
Updated: Sep 26, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE
Takeshi Yoshimoto1,2, Kazunori Toyoda3, Masafumi Ihara1
1Department of Neurology (T. Yoshimoto, M.I.), National Cerebral and Cardiovascular Center, Suita, Japan.
Insights
Elderly patients with nonvalvular atrial fibrillation and prior stroke/TIA face higher risks of stroke, bleeding, and death. Direct oral anticoagulants reduced hemorrhagic events compared to warfarin in these patients.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Nonvalvular atrial fibrillation (NVAF) is a common condition in the elderly.
- Stroke and transient ischemic attack (TIA) are significant complications of NVAF.
- Understanding long-term event incidence in elderly NVAF patients based on stroke history and anticoagulation is crucial.
Purpose of the Study:
- To determine long-term event incidence in elderly NVAF patients.
- To compare outcomes between NVAF patients with and without a history of stroke/TIA.
- To evaluate the safety and efficacy of direct oral anticoagulants (DOACs) versus warfarin in NVAF patients with prior ischemic stroke/TIA.
Main Methods:
- Prospective, multicenter, observational study of NVAF patients aged ≥75 years.
- Patients were divided into groups based on history of stroke/TIA.
- Primary endpoint: stroke/systemic embolism within 2 years. Secondary endpoints: major bleeding and all-cause death within 2 years. Cox models were used for analysis.
Main Results:
- Over 32,000 patients were analyzed; 22.6% had a history of stroke/TIA.
- Patients with prior stroke/TIA had higher risks of stroke/systemic embolism, major bleeding, and all-cause death.
- Among patients with prior ischemic stroke/TIA, DOACs were associated with lower risks of major bleeding, intracranial hemorrhage, and cardiovascular death compared to warfarin.
Conclusions:
- Elderly NVAF patients with a history of stroke/TIA experience more subsequent ischemic and hemorrhagic events.
- DOACs demonstrate a favorable safety profile regarding hemorrhagic events in NVAF patients with prior ischemic stroke/TIA compared to warfarin.
Background:
We determined the long-term event incidence among elderly patients with nonvalvular atrial fibrillation in terms of history of stroke/transient ischemic attack (TIA) and oral anticoagulation.
Methods:
Patients aged ≥75 years with documented nonvalvular atrial fibrillation enrolled in the prospective, multicenter, observational All Nippon Atrial Fibrillation in the Elderly Registry between October 2016 and January 2018 were divided into 2 groups according to history of stroke/TIA. The primary end point was the occurrence of stroke/systemic embolism within 2 years, and secondary end points were major bleeding and all-cause death within 2 years. Cox models were used to determine whether there was a difference in the hazard of each end point in patients with/without history of stroke/TIA, and in ischemic stroke/TIA survivors taking direct oral anticoagulants versus those taking warfarin.
Results:
Of 32 275 evaluable patients (13 793 women [42.7%]; median age, 81.0 years), 7304 (22.6%) had a history of stroke/TIA. The patients with previous stroke/TIA were more likely to be male and older and had higher hazard rates of stroke/systemic embolism (adjusted hazard ratio, 2.25 [95% CI, 1.97-2.58]), major bleeding (1.25, 1.05-1.49), and all-cause death (1.13, 1.02-1.24) than the other groups. Of 6446 patients with prior ischemic stroke/TIA, 4393 (68.2%) were taking direct oral anticoagulants and 1668 (25.9%) were taking warfarin at enrollment. The risk of stroke/systemic embolism was comparable between these 2 groups (adjusted hazard ratio, 0.90 [95% CI, 0.71-1.14]), while the risk of major bleeding (0.67, 0.48-0.94), intracranial hemorrhage (0.57, 0.39-0.85), and cardiovascular death (0.71, 0.51-0.99) was lower among those taking direct oral anticoagulants.
Conclusions:
Patients aged ≥75 years with nonvalvular atrial fibrillation and previous stroke/TIA more commonly had subsequent ischemic and hemorrhagic events than those without previous stroke/TIA. Among patients with previous ischemic stroke/TIA, the risk of hemorrhagic events was lower in patients taking direct oral anticoagulants compared with warfarin.
Registration:
URL: https://www.
Clinicaltrials:
gov; Unique Identifier: UMIN000024006.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis IV: Nursing Management
Heart Failure III: Clinical Manifestations

